Among the 19 GIRlncRNA signature, 14 lncRNAs (AC023824.3, AC013287.1, AP000829.1, LINC01611, AC097451.1, AC025419.1, AC079949.2, LINC01600, AC004862.1, AC021594.1, MYRF-AS1, LINC02434, LINC02412, and LINC00337) were risk factors for prognosis, while the other five lncRNAs (LINC01067, AC012645.1, AL512604.3, AC008278.2, and AC089998.1) were protective factors for survival of NSCLC patients. Here, MYRF is linked to non-small cell lung carcinoma.